THC Farmaceuticals Interest Coverage
Interest Coverage Ratio of THC Farmaceuticals (CBDG) as of Aug 10, 2026.
Get this data via API
Financial Data API
Interest Coverage
0.00
Last updated:
Interest Coverage Ratio of THC Farmaceuticals is 2026 0.00 . Interest Coverage Ratio of THC Farmaceuticals was 2025 0.00 . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API
THC Farmaceuticals Stock analysis
What does THC Farmaceuticals do? THC Farmaceuticals Inc. is a Canadian company specializing in the production of medical cannabis products. It was founded in 2015 and is headquartered in Langley, British Columbia. The company is a registered publicly traded company, listed on the Canadian Securities Exchange (CSE) under the symbol THC and also traded on the OTC market in the USA.
The company was founded by two friends, John Miller and Erik Shaw, who were both involved in agriculture and had a mutual interest in medical cannabis. They recognized the potential of the plant and began growing their own strains. Over time, they developed unique cultivars that were rich in cannabinoids and had a high therapeutic effect. Their approach has always been to produce medical cannabis of the highest quality and purity.
In 2017, THC Farmaceuticals obtained the license to produce medical cannabis and started bringing its products to the market. The company has since grown in Canada and the USA and expanded its presence in the international market.
THC Farmaceuticals' business model focuses on the production of medical cannabis. The company cultivates its own plants and extracts cannabinoids. The extraction of cannabinoids, such as THC and CBD, is an essential step in the production of medical cannabis. These components are offered by THC Farmaceuticals in different concentrations to meet the needs of customers.
In addition, the company focuses on producing products for the medical and recreational sectors. The offered products include cannabis concentrates, oils, capsules, inhalation devices, and edible products such as candies and chocolates. THC Farmaceuticals stands out for its wide range of products to meet the needs of consumers and patients with different requirements.
THC Farmaceuticals focuses on two main areas:
1. Medical sector: THC Farmaceuticals offers a wide range of cannabis products for patients with various conditions. The company works closely with doctors and healthcare professionals to ensure its products meet the needs of patients. There are numerous studies that demonstrate the efficacy of medical cannabis in treating various conditions, such as pain, epilepsy, cancer, and multiple sclerosis.
2. Recreational sector: THC Farmaceuticals also offers a wide range of cannabis products for the recreational sector. These products are intended for adults who consume cannabis for pleasure or relaxation. There is a growing demand for recreational cannabis products in Canada and the USA, especially after the legalization of cannabis in some states.
THC Farmaceuticals offers a wide range of cannabis products suitable for the medical and recreational sectors. Some of the products offered by the company include:
1. Cannabis concentrates: These are highly concentrated forms of cannabis with a high therapeutic effect. THC Farmaceuticals offers a wide selection of concentrate forms, including oils, extracts, and isolates.
2. Edible products: THC Farmaceuticals offers a wide range of edible cannabis products, such as chocolates and candies. These products are a popular way to consume cannabis without smoking or inhaling it.
3. Inhalation devices: THC Farmaceuticals offers a wide range of inhalation devices, such as vaporizers and e-cigarettes. These devices provide an effective and gentle way to inhale cannabis.
In conclusion, THC Farmaceuticals is a rising company specializing in the production of medical cannabis products. The company offers a wide range of products suitable for the medical and recreational sectors. With its extensive range and commitment to quality and purity, THC Farmaceuticals has become a major player in the cannabis market. THC Farmaceuticals is one of the most popular companies on Eulerpool.
Frequently Asked Questions about THC Farmaceuticals stock
On Eulerpool you can find the complete historical development of Interest Coverage Ratio THC Farmaceuticals since 2006 – with annual values, charts, and detailed analysis.
The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.
Interest Coverage = EBIT / Interest Expense
A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's THC Farmaceuticals with sector peers and the industry average to assess whether it is attractive.
Access this data via the Eulerpool API
Leverage — THC Farmaceuticals
All Key Metrics — THC Farmaceuticals
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth